Farmaflex SRL
Farmaflex reported total assets of 549,186 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Farmaflex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets +25 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmaflex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Farmaflex's financial analysis
- Solvency27.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmaflex
Farmaflex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.701.675
- VAT number
- BE0430701675
- Peppol
- Registered · 0208:0430701675 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Mar 1987
- Registered office
- 2100 Antwerp
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmaflex (SRL) has been based in Antwerp since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 578 € and equity of 151,191 €; its revenue is not published. Its solvency stands at 27.5%, below the median of its sector (44.0%).
Companies similar to Farmaflex
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Clessens Retail sale of pharmaceutical products Antwerp · balance sheet €1.19m
- Camba-Pharma Retail sale of pharmaceutical products Ghent · balance sheet 437,825 €
- Demapharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 659,253 €
- B&B Pharma Retail sale of pharmaceutical products Beersel · balance sheet 811,436 €
- Bloos Retail sale of pharmaceutical products Anzegem · balance sheet 824,528 €
- Pharmacie Lejong Retail sale of pharmaceutical products Morlanwelz · balance sheet 653,943 €
- Donk DCL Farma Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 897,538 €
- Welzijn Retail sale of pharmaceutical products Antwerp · balance sheet 520,956 €
Frequently asked questions about Farmaflex
What is the revenue of Farmaflex?
Farmaflex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmaflex?
In Belgium, the VAT number is the company number prefixed with BE: BE0430701675 for Farmaflex, if the company is VAT-registered. Its company number (CBE) is 0430.701.675.
Where is the registered office of Farmaflex?
According to the CBE register, the registered office of Farmaflex is in 2100 Antwerp.
What is the equity of Farmaflex?
At the close of the 2025 financial year, the equity of Farmaflex amounts to 151,191 €, a solvency of 27.5% of total assets.
Who manages Farmaflex?
The register lists 2 active mandates at Farmaflex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmaflex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →